FRI0128 A Phase III Randomised, Double-Blind Clinical Study Comparing SB4, An Etanercept Biosimilar, With Etanercept Reference Product (Enbrel®) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy (24-Week Results)
Vencovský, J., Sylwestrzak, A., Leszczyński, P., Porawska, W., Baranauskaite, A., Tseluyko, V., Zhdan, V., Stasiuk, B., Milasiene, R., Barrera Rodriguez, A.A., Cheong, S.Y., Ghil, J., Emery, P.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article